Wockhardt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LANSOPRAZOLE USP, with a corresponding US DMF Number 21605.
Remarkably, this DMF maintains an Active status since its submission on April 23, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 17, 2013, and payment made on March 06, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II